发明名称 |
FUSION POLYPEPTIDES AND USES THEREOF |
摘要 |
The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides. |
申请公布号 |
US2015329613(A1) |
申请公布日期 |
2015.11.19 |
申请号 |
US201314655617 |
申请日期 |
2013.12.20 |
申请人 |
BAYER PHARMA AKTIENGESELLSCHAFT |
发明人 |
WILMEN Andreas;LEINEWEBER Kirsten;SCHEERER Nina Alexandra;JÖRIßEN Hannah |
分类号 |
C07K14/64;C07K16/00 |
主分类号 |
C07K14/64 |
代理机构 |
|
代理人 |
|
主权项 |
1. A fusion polypeptide having Relaxin activity comprising in order from the amino-terminus to the carboxy-terminus:
a. a IgG2 or IgG4 Fc domain, b. a stretcher unit, and c. the scRelaxin polypeptide having the underlined sequence as shown in FIG. 2. |
地址 |
Berlin DE |